These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30458259)

  • 41. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
    Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.
    Chang CW; Wong CY; Wu YT; Hsu MC
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):239-249. PubMed ID: 27118361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D; Potter CB; Walker GM; Higginbotham CL
    J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of some acrylic polymers on dissolution of celecoxib solid dispersion formulations.
    Maghsoodi M; Nokhodchi A; Pourasghari Azar H
    Pharm Dev Technol; 2021 Sep; 26(7):788-796. PubMed ID: 34159879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
    Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS
    Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
    Chavan RB; Modi SR; Bansal AK
    Int J Pharm; 2015 Nov; 495(1):374-384. PubMed ID: 26364711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation.
    Angi R; Solymosi T; Erdősi N; Jordán T; Kárpáti B; Basa-Dénes O; Ujhelyi A; McDermott J; Roe C; Mair S; Ötvös Z; Molnár L; Glavinas H
    AAPS PharmSciTech; 2019 Jan; 20(2):90. PubMed ID: 30684094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability.
    Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Song SH; Chae BR; Choi YW
    Int J Pharm; 2016 Jun; 506(1-2):302-11. PubMed ID: 27125455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
    Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
    Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
    Sawicki E; Schellens JH; Beijnen JH; Nuijen B
    Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revealing Changes in Celecoxib Nanostructured Lipid Carrier's Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS.
    Zhu Y; Chen M; Yang C; Lu G; Huang S; Chen M; Wang Y; Ban J
    Drug Des Devel Ther; 2024; 18():3315-3327. PubMed ID: 39100220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.